News

11.05.26 Medannex Secures SMART grant to develop a ‘biological missile’ to tackle cancers
01.05.26 Medannex presents clinical data at the Cholangiocarcinoma Foundation’s Annual Conference
12.03.26 Medannex Receives Scottish Life Sciences Innovation Award
20.10.25 Medannex Unveils Positive Clinical Data on MDX-124 at ESMO 2025
02.10.25 Medannex’s First-in-Class Therapeutic Granted FDA Orphan Drug Designation for Biliary Tract Cancer
21.03.25 Medannex unveils novel approach to osteosarcoma treatment at ESMO Meeting
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7